Definitive Healthcare Corp. announced the availability of Latitude Discovery, a new product aimed at pre-commercial biopharma and medical device companies. With Latitude Discovery, users can quickly perform iterative analysis of real-world data to assess and size potential market opportunities associated with therapy development for granular patient cohorts.

Latitude Discovery is purposefully designed to meet the needs of pre-commercial pharmaceutical, biotechnology and medical device companies who are looking to bring new treatments to market. With billions of commercial medical claims, Latitude Discovery users gain self-service access to the precise market intelligence they need when they need it as they advance through the lengthy commercialization process. Key capabilities of Latitude Discovery include: The ability to quickly create new patient cohorts for analysis and reporting using any combination of diagnosis or procedure with additional filters on patients and providers; Rapid real-time commercial intelligence visualizations on the size of addressable patient and provider populations, clinical volumes, demographics and payor mix; Customizable claims data report templates to understand all additional diagnoses and procedures associated with the target population.